U.S. President Donald Trump makes a statement to reporters about reopening churches across the United States during the coronavirus disease (COVID-19) pandemic in the Brady Press Briefing Room at the White House in Washington, May 22, 2020.
Leah Millis | Reuters
President Donald Trump said Friday the U.S. has already produced 2 million coronavirus vaccine doses that are “ready to go” once scientists figure out whether it is safe and effective.
“Tremendous progress is being made on vaccines,” Trump said during a Friday morning press conference from the White House. “In fact, we’re ready to go in terms of transportation and logistics. We have over 2 million ready to go if it checks out for safety.”
Trump said “we’re doing incredibly well” on vaccines, adding, “I think you’re going to have some very positive surprises and therapeutics likewise we’re doing extremely well. Cures, we’re doing well.”
The Trump administration has selected five companies as the most likely candidates to produce a vaccine for the coronavirus, according to the New York Times. He didn’t say Friday which ones have started vaccine production.
The National Institutes of Health has been fast-tracking work with biotech firm Moderna on a potential vaccine to prevent Covid-19. White House health advisor Dr. Anthony Fauci said earlier this week that there are at least four trials for potential vaccines that he is either directly or indirectly involved in.
Because of the pandemic, U.S. health officials and researchers have been accelerating the development of vaccines candidate by investing in multiple stages of research even though doing so could be for naught if the vaccine ends up not being effective or safe.
U.S. officials and scientists are hopeful a vaccine to prevent Covid-19 will be ready in the first half of 2021.
Trump said Friday that U.S. officials “understand the disease now.” However, scientists have said they still don’t fully understand key aspects of the virus, including how immune systems respond once a person is exposed.
This is a developing story. Please check back for updates.